LEGN
Legend Biotech·NASDAQ
--
--(--)
--
--(--)
LEGN fundamentals
Legend Biotech (LEGN) Revenue Breakdown: Q3 2025 Business & Regional Performance
Legend Biotech (LEGN) reported total revenue of 272.33M USD in Q3 2025, with its core business segment License and Collaboration Revenue contributing 99.99%. Regionally, North America remained the largest market, accounting for 76.49% of total revenue. Explore Legend Biotech's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Legend Biotech (LEGN) reported total revenue of 272.33M USD in Q3 2025, with its core business segment License and Collaboration Revenue contributing 99.99%. Regionally, North America remained the largest market, accounting for 76.49% of total revenue. Explore Legend Biotech's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the revenue and EPS growth rate for Legend Biotech year over year?What factors drove the changes in Legend Biotech's revenue and profit?What were the key takeaways from Legend Biotech's earnings call?What were the key takeaways from Legend Biotech’s earnings call?What guidance did Legend Biotech's management provide for the next earnings period?What does Legend Biotech do and what are its main business segments?What is Legend Biotech's gross profit margin?Did Legend Biotech beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
